Advertisement

Topics

Viropro Inc. (VPRO) - Financial and Strategic SWOT Analysis Review

04:48 EST 26 Nov 2014 | BioPortfolio

This article has expired, however you can still download the PDF.
Preview:
Summary Viropro, Inc. (Viropro) is a pharmaceutical company. The company develops and manufactures therapeutic monoclonal antibodies. Its products include Rituximab, Trastuzumab, Infliximab, Etanercept and Bevacizumab. Viropro offers services, such as cel....

Other Sources for this Article

Original Article: Viropro Inc. (VPRO) - Financial and Strategic SWOT Analysis Review

NEXT ARTICLE

More From BioPortfolio on "Viropro Inc. (VPRO) - Financial and Strategic SWOT Analysis Review"

Advertisement
Quick Search
Advertisement
Advertisement